238 related articles for article (PubMed ID: 22005044)
21. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
Burashnikov A; Di Diego JM; Sicouri S; Ferreiro M; Carlsson L; Antzelevitch C
Heart Rhythm; 2008 Dec; 5(12):1735-42. PubMed ID: 19084813
[TBL] [Abstract][Full Text] [Related]
22. Ranolazine terminates atrial flutter and fibrillation in a canine model.
Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical model.
Nesterenko VV; Zygmunt AC; Rajamani S; Belardinelli L; Antzelevitch C
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1615-24. PubMed ID: 21821780
[TBL] [Abstract][Full Text] [Related]
24. In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.
Aguilar-Shardonofsky M; Vigmond EJ; Nattel S; Comtois P
Biophys J; 2012 Mar; 102(5):951-60. PubMed ID: 22404917
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological effects of ranolazine in a goat model of lone atrial fibrillation.
Opačić D; van Hunnik A; Zeemering S; Dhalla A; Belardinelli L; Schotten U; Verheule S
Heart Rhythm; 2021 Apr; 18(4):615-622. PubMed ID: 33232809
[TBL] [Abstract][Full Text] [Related]
26. Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
Carvas M; Nascimento BC; Acar M; Nearing BD; Belardinelli L; Verrier RL
J Cardiovasc Pharmacol; 2010 Mar; 55(3):286-91. PubMed ID: 20075744
[TBL] [Abstract][Full Text] [Related]
27. Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Sicouri S; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Heart Rhythm; 2012 Mar; 9(3):422-9. PubMed ID: 22019863
[TBL] [Abstract][Full Text] [Related]
28. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
Antzelevitch C; Burashnikov A
J Electrocardiol; 2009; 42(6):543-8. PubMed ID: 19698954
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.
Sicouri S; Blazek J; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):371-9. PubMed ID: 22407414
[TBL] [Abstract][Full Text] [Related]
30. Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.
Burashnikov A; Barajas-Martinez H; Hu D; Nof E; Blazek J; Antzelevitch C
J Cardiovasc Pharmacol; 2012 Jun; 59(6):539-46. PubMed ID: 22370957
[TBL] [Abstract][Full Text] [Related]
31. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
[TBL] [Abstract][Full Text] [Related]
32. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
[TBL] [Abstract][Full Text] [Related]
33. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2010 Sep; 7(9):1273-9. PubMed ID: 20478403
[TBL] [Abstract][Full Text] [Related]
34. Atria are More Sensitive Than Ventricles to GS-458967-Induced Inhibition of Late Sodium Current.
Burashnikov A; Di Diego JM; Goodrow RJ; Belardinelli L; Antzelevitch C
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):501-8. PubMed ID: 25652294
[TBL] [Abstract][Full Text] [Related]
35. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
Comtois P; Sakabe M; Vigmond EJ; Munoz M; Texier A; Shiroshita-Takeshita A; Nattel S
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1489-504. PubMed ID: 18676686
[TBL] [Abstract][Full Text] [Related]
37. In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of I
Nunoi Y; Kambayashi R; Goto A; Hagiwara-Nagasawa M; Chiba K; Izumi-Nakaseko H; Kawai S; Takei Y; Matsumoto A; Watanabe Y; Sugiyama A
Heart Vessels; 2021 Jul; 36(7):1088-1097. PubMed ID: 33763729
[TBL] [Abstract][Full Text] [Related]
38. Is ranolazine an antiarrhythmic drug?
Eckhardt LL; Teelin TC; January CT
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1989-91. PubMed ID: 18375723
[No Abstract] [Full Text] [Related]
39. Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts.
Chu Y; Yang Q; Ren L; Yu S; Liu Z; Chen Y; Wei X; Huang S; Song L; Zhang P; Ma J; Wu L
J Cardiovasc Pharmacol; 2020 Oct; 76(4):437-444. PubMed ID: 32675747
[TBL] [Abstract][Full Text] [Related]
40. Influence of propafenone on resetting and termination of canine atrial flutter.
Mensour B; Jalil E; Vinet A; Kus T
Pacing Clin Electrophysiol; 2000 Aug; 23(8):1200-19. PubMed ID: 10962741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
